The Administrative Core will provide comprehensive and cohesive support in administrative, fiscal and programmatic aspects of the Program Project. It will also interface with the University of Pennsylvania, the Wistar Institute, Fox Chase Cancer Center and the National Cancer Institute (NCI). The Administrative Core, in geographical proximity to the scientific core facilities and the laboratories of the project leaders, will serve many organizational and fiscal functions. These include generation and analysis of monthly budget reports, interfacing with the medical school's research services, coordinating clinical/translational programs, and completing NCI requirements. In addition, the administrative core will continue to coordinate monthly meetings with the project and core facilities leaders;weekly core facilities'meetings;regular research seminars/journal clubs/laboratory meetings;maintain a library, newsletter and website;and promote the program project within the university and medical school (especially as it relates to the internal advisory board-lAB), as well as regionally and nationally. Importantly, the Core will organize the annual conference/retreat in conjunction with the review by the external advisory board (EAB). All IAB and EAB reports will be organized by the Core that will be shared with the Dean, Cancer Center Director, Wistar Institute Director and the NCI. As additional measures, the Core will organize workshops in grant writing, manuscript writing, and career development for students, postdoctoral fellows and junior faculty in the Program Project. It will expand the human tissue banking efforts of the Morphology and Molecular Biology Cores, promote the relational databases of the Molecular Biology Core, ensure appropriate bioinformatics support through the Molecular Biology Core and integrate the new Biostatistics Core. The Administrative Core will advance the innovative and far-reaching goals articulated and envisioned by the Program Project. In aggregate, the administrative core, already in existence, will enhance the intellectual, scientific, structural and fiscal components of the Program Project. Individually and together, Drs. Rustgi and Herlyn and Ms. Hay have vast experience in administration and ensuring thematic integration between the Projects and Cores.

Public Health Relevance

This Core is critical to the growth and expansion of the Program Project at Penn, regionally, nationally, and internationally. It achieves prominence of the Program Project by integrating the Projects, providing support for the other cores, nurturing new investigators-into the field, expanding the repetoire of the databases/reagents of the Program Project, and working closely with institutional leadership and the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA098101-06A1
Application #
7659190
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (J1))
Project Start
2009-04-01
Project End
2014-03-31
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
6
Fiscal Year
2009
Total Cost
$102,411
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Campbell, Joshua D; Yau, Christina; Bowlby, Reanne et al. (2018) Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Rep 23:194-212.e6
Whelan, Kelly A; Muir, Amanda B; Nakagawa, Hiroshi (2018) Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine. Cell Mol Gastroenterol Hepatol 5:461-478
Giroux, VĂ©ronique; Stephan, Julien; Chatterji, Priya et al. (2018) Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem Cell Reports 10:1947-1958
Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705
Adeegbe, Dennis O; Liu, Shengwu; Hattersley, Maureen M et al. (2018) BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer. Cancer Immunol Res 6:1234-1245
Stachler, Matthew D; Camarda, Nicholas D; Deitrick, Christopher et al. (2018) Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma. Gastroenterology 155:156-167
Bockorny, Bruno; Rusan, Maria; Chen, Wankun et al. (2018) RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade. Mol Cancer Ther 17:1526-1539
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977
Karakasheva, Tatiana A; Dominguez, George A; Hashimoto, Ayumi et al. (2018) CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. JCI Insight 3:

Showing the most recent 10 out of 173 publications